PEDIATRIC SOLID TUMOR
Clinical trials for PEDIATRIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for PEDIATRIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to halt Cancer's deadly spread
Disease control Recruiting nowThis early-phase trial tests a new drug called metarrestin in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors or stop them from growing further. The study includes adults with certain cancers and children aged 12…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a treatment where a child's own immune cells are collected, modified to better attack cancer, and given back as a one-time infusion. It is for children and young adults up to age 21 with solid tumors that have come back or not responded to standard th…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
New drug cocktail shows promise for kids with rare cancers
Disease control Recruiting nowThis study tests a combination of four drugs (cyclophosphamide, sorafenib, bevacizumab, and atezolizumab) in children and young adults with solid tumors that have come back or not responded to treatment. The goal is to find safe doses and see if the drugs shrink tumors. The trial…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Diabetes drug repurposed to fight childhood cancers in early safety trial
Disease control Recruiting nowThis early-phase study tests whether dapagliflozin, a diabetes medicine, is safe for children with brain or solid tumors that have come back or not responded to standard treatments. About 20 children will receive the drug alongside their usual care. The goal is to check for side …
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Scientists launch massive effort to decode rare tumors
Knowledge-focused Recruiting nowThis study aims to better understand rare solid tumors by collecting biological samples (like blood, saliva, and tumor tissue) and health information from up to 10,000 people over many years. Participants include people with a rare tumor, those with a genetic risk for one, and th…
Matched conditions: PEDIATRIC SOLID TUMOR
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC